Skip to main content

Innovation challenges are all the rage with pharma, and they’re likely here to stay: study | FiercePharma

By October 15, 2018News
pharma-drugs-pixa

pharma-drugs-pixa

The number of open innovation challenges in pharma grows by the day. But what’s driving them? That’s what Luminary Labs wanted to know. So the consultancy, which works with pharma and other industries to design and execute those kind of challenges, surveyed the executives at companies that run the contests and asked why and how they do it.

{iframe}https://www.fiercepharma.com/marketing/innovation-throwdowns-all-rage-pharma-and-other-industries-but-likely-here-to-stay-study{/iframe}

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.